Cover Image

Safety and Efficacy of Misoprostol versus Oxytocin for the Prevention of Postpartum Hemorrhage

Postpartum hemorrhage (PPH) is the commonest cause of maternal death worldwide. Studies suggest that the use of misoprostol may be beneficial in clinical settings where oxytocin is unavailable. The aim of this study was to compare the safety and efficacy of oxytocin and misoprostol when used in the...

Full description

Saved in:

Bibliographic Details
Main Authors:	Minoo Rajaei (Author), Samieh Karimi (Author), Zohreh Shahboodaghi (Author), Hamidreza Mahboobi (Author), Tahereh Khorgoei (Author), Farzam Rajaei (Author)
Format:	Book
Published:	Hindawi Limited, 2014-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and Safety of Misoprostol Administered Rectally Compared with Oxytocin for the Prevention of Postpartum Hemorrhage
by: Shama Chaudhry, et al.
Published: (2024)

Oxytocin Versus Misoprostol Plus Oxytocin in the Prevention of Postpartum Hemorrhage at a Semi-Urban Hospital in sub-Saharan Africa: A Retrospective Cohort Study
by: Emmanuel Numfor, BSc, et al.
Published: (2020)

Prevention of Postpartum Hemorrhage with Oxytocin versus Ergometrine Plus Oxytocin in the third stage of labor
by: Thitipun Nuamsiri, et al.
Published: (2016)

Oxytocin quality: evidence to support updated global recommendations on oxytocin for postpartum hemorrhage
by: Peter Lambert, et al.
Published: (2020)

Comparison of Carbetocin and Oxytocin Efficacy in Preventing Postpartum Hemorrhage after C-Section
by: Yarramsetti V. Rao, et al.
Published: (2024)

Effects of a New Patient Safety-Driven Oxytocin Dosing Protocol on Postpartum Hemorrhage
by: David S. McKenna, et al.
Published: (2014)

Cost-effectiveness and budget impact of heat-stable carbetocin compared to oxytocin and misoprostol for the prevention of postpartum hemorrhage (PPH) in women giving birth in India
by: John R. Cook, et al.
Published: (2023)

Carbetocin versus oxytocin for prevention of postpartum hemorrhage in hypertensive women undergoing elective cesarean section
by: Zakia M. Ibrahim, et al.
Published: (2020)

Comparison of the effects and side effects of misoprostol and oxytocin in the postpartum period: A systematic review
by: Zümrüt Bilgin, et al.
Published: (2019)

Efficacy of misoprostol for the treatment of postpartum hemorrhage: current knowledge and implications for health care planning
by: Prata N, et al.
Published: (2016)

Evaluation the frequency of factor V Leiden mutation in pregnant women with preeclampsia syndrome in an Iranian population
by: Azadeh Azinfar, et al.
Published: (2012)

INTRAMUSCULAR OXYTOCIN SHOULD IT BE INJECTED AS ROUTINE TO CONTROL POSTPARTUM HEMORRHAGE?
by: Mooshkbid Haghighi, M, et al.
Published: (2001)

Current form of randomized controlled trials
by: Hamidreza Mahboobi, et al.
Published: (2011)

Carbetocin versus oxytocin for prevention of postpartum hemorrhage in infertile women with twin pregnancy undergoing elective cesarean delivery
by: Kok-Min Seow, et al.
Published: (2017)

Carbetocin versus oxytocin for the prevention of postpartum hemorrhage: A meta-analysis of randomized controlled trials in cesarean deliveries
by: Hian Yan Voon, et al.
Published: (2018)

Carbetocin versus Oxytocin for the Prevention of Postpartum Hemorrhage in Cesarean Deliveries: A Retrospective Study of Two Consecutive Periods
by: Pierre Delorme, et al.
Published: (2020)

A Randomized Control Trial of 3 IU IV Oxytocin Bolus with 7 IU Oxytocin Infusion versus 10 IU Oxytocin Infusion During Cesarean Section for Prevention of Postpartum Hemorrhage
by: Yaliwal RG, et al.
Published: (2020)

A randomized controlled trial of 3 IU Intravenous oxytocin bolus with 7 IU oxytocin infusion versus 10 IU oxytocin intramuscular in the third stage of labor for the prevention of postpartum hemorrhage
by: Shivakumar Pujeri
Published: (2020)

Comparative study between intramyometrial oxytocin and oxytocin analogue (carbetocin) in prevention of postpartum hemorrhage following cesarean section
by: Farid A Kassab, et al.
Published: (2021)

Quality, availability and storage conditions of oxytocin and misoprostol in Malawi
by: Nhomsai Hagen, et al.
Published: (2020)

Effects of Motherwort Injection Versus Intramuscular Oxytocin for Preventing Postpartum Hemorrhage Among Women Who Underwent Cesarean Section
by: Ming-xi Li, et al.
Published: (2022)

Oxytocin receptor single nucleotide polymorphism predicts atony-related postpartum hemorrhage
by: Elise N. Erickson, et al.
Published: (2022)

Efficacy of Rectal Misoprostol versus Oxytocin on Reducing Blood Loss during Cesarean Section: A Meta-Analysis of Randomized Clinical Trials
by: Ebraheem Albazee, et al.
Published: (2022)

A comparative study on infusion of usual dose of oxytocin and 80 units dose of oxytocin in the prevention of postpartum hemorrhage in cesarean section
by: Fatemeh Ahmadi
Published: (2018)

Side-effects of intravenously versus intramuscularly oxytocin for postpartum hemorrhage: a systematic review and meta-analysis of randomized controlled trials
by: Wen Ai, et al.
Published: (2023)

Oral Misoprostol alone versus oral misoprostol followed by oxytocin for labour induction in women with hypertension in pregnancy (MOLI): protocol for a randomised controlled trial
by: Hillary Bracken, et al.
Published: (2021)

Oxytocin via Uniject (a prefilled single-use injection) versus oral misoprostol for prevention of postpartum haemorrhage at the community level: a cluster-randomised controlled trial
by: Ayisha Diop, MPH, et al.
Published: (2016)

Cost-effectiveness of Carbetocin versus Oxytocin for Prevention of Postpartum Hemorrhage Resulting from Uterine Atony in Women at high-risk for bleeding in Colombia
by: Yaneth Gil-Rojas, et al.
Published: (2018)

Sublingual misoprostol versus intravenous oxytocin in reducing bleeding during and after cesarean delivery: A randomized clinical trial
by: Essam Rashad Othman, et al.
Published: (2016)

Dose and side effects of sublingual misoprostol for treatment of postpartum hemorrhage: what difference do they make?
by: León Wilfrido, et al.
Published: (2012)

Intrauterine Misoprostol plus Intravenous Oxytocin for Reduction of Blood Loss in Cesarean Delivery
by: Wirawan Rasri
Published: (2018)

Misoprostol as an adjunct to oxytocin can reduce postpartum-haemorrhage: a propensity score-matched retrospective chart review in Bamenda-Cameroon, 2015-2016
by: Frederick Morfaw, et al.
Published: (2019)

Side Effects of Misoprostol Per Rectal for Treating Postpartum Hemorrhage in Vaginal Delivery versus Cesarean Section: What Do We Know So Far?
by: Novitasari Nasution, et al.
Published: (2020)

To study the efficacy of misoprostol compared with methyl ergometrine for prevention of postpartum haemorrhage
by: Varsha Kotwal
Published: (2019)

Intravenous Administration of Carbetocin Versus Oxytocin for Preventing Postpartum Hemorrhage After Vaginal Delivery in High Risk Women: A Double-blind, Randomized Controlled Trial
by: Hua Liu, et al.
Published: (2020)

Efficacy and safety of isosorbide mononitrate plus misoprostol compared to misoprostol alone in the management of the first and second trimester abortion: a systematic review and meta-analysis
by: Somayeh Makvandi, et al.
Published: (2024)

Misoprostol in addition to routine treatment of postpartum hemorrhage: A hospital-based randomized-controlled trial in Karachi, Pakistan
by: Blum Jennifer, et al.
Published: (2008)

Carbetocin versus oxytocin for the prevention of postpartum hemorrhage after elective caesarean section in high risk women: a prospective, randomized, open-label, controlled trial in China
by: Suya Kang, et al.
Published: (2022)

Promptness of oxytocin administration for first-line treatment of postpartum hemorrhage: a national vignette-based study among midwives
by: S. Voillequin, et al.
Published: (2022)

A Comparison Between Sublingual Misoprostol and Intravenous Oxytocin for Inducing labor in Women with Term Pregnancy
by: Leila Habibi, et al.
Published: (2012)